5526 - 5550 of 9145 Results
Title
Year
-
OPENTitle: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficitsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page: 45End Page: 45Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2014.00045Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/e22b18ef-cfd0-44ba-94e7-0eeb4bd9ebebCitation Count: 104
-
OPENTitle: Functional Brain Imaging Synthesis Based on Image Decomposition and Kernel Modeling: Application to Neurodegenerative DiseasesJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 65End Page: 65Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2017.00065Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2017.00065/pdfCitation Count: 20
-
OPENTitle: Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's DiseaseJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2018.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2018.00053/pdfCitation Count: 54
- Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease2015OPENTitle: Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 101End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00101Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00101/pdfCitation Count: 71
-
OPENTitle: An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI CohortJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 18Start Page: 6562End Page: 6562Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21186562Best OA location URL: https://www.mdpi.com/1422-0067/21/18/6562/pdfCitation Count: 43
-
OPENTitle: Probabilistic conversion of neurosurgical DBS electrode coordinates into MNI spaceJournal Name: NeuroImagePublisher: Elsevier BVVol: 150Issue #:Start Page: 395End Page: 404Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6050588Citation Count: 165
-
OPENTitle: The “Michael Foundation”—A foundation against epilepsyJournal Name: EpilepsiaPublisher: WileyVol: 55Issue #: 6Start Page: 803End Page: 805Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/epi.12509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12509Citation Count: 0
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Fox Trial Finder, un nouvel outil pour la recherche clinique2014RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
-
OPENTitle: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assayJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 5Start Page: 696End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51753Citation Count: 35
-
OPENTitle: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceJournal Name: Value in HealthPublisher: Elsevier BVVol: 26Issue #: 4Start Page: 449End Page: 460Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006Best OA location URL: http://www.valueinhealthjournal.com/article/S1098301522047805/pdfCitation Count: 40
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 40
-
OPENTitle: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In VivoJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 148Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/59758-vBest OA location URL: https://www.jove.com/pdf/59758/generation-alpha-synuclein-preformed-fibrils-from-monomers-useCitation Count: 47
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
-
OPENTitle: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S MutationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1541End Page: 1545Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29449Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10524857/pdf/nihms-1899906.pdfCitation Count: 20
- Shifting the trajectory of therapeutic development for neurological and psychiatric disorders2023RESTRICTEDTitle: Shifting the trajectory of therapeutic development for neurological and psychiatric disordersJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 720Start Page: eadg4775End Page: eadg4775Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adg4775Citation Count: 12
-
OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 95
-
OPENTitle: α-synuclein Imaging: A Critical Need for Parkinson's Disease ResearchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 3Issue #: 4Start Page: 565End Page: 567Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130247Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130247?id=journal-of-parkinsons-disease%2Fjpd130247Citation Count: 81
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
-
OPENTitle: A Culturally Tailored Community Health Worker Intervention Leads to Improvement in Patient-Centered Outcomes for Immigrant Patients With Type 2 DiabetesJournal Name: Clinical DiabetesPublisher: American Diabetes AssociationVol: 36Issue #: 2Start Page: 100End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2337/cd17-0068Best OA location URL: https://clinical.diabetesjournals.org/content/diaclin/36/2/100.full.pdfCitation Count: 61